Skip to main content

TEVA 5347 Pill - white capsule/oblong, 18mm

Pill with imprint TEVA 5347 is White, Capsule/Oblong and has been identified as Methylphenidate Hydrochloride Extended-Release (LA) 30 mg. It is supplied by Teva Pharmaceuticals USA Inc.

Methylphenidate is used in the treatment of ADHD; Narcolepsy; Depression and belongs to the drug class CNS stimulants. Risk cannot be ruled out during pregnancy. Methylphenidate 30 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).

Images for TEVA 5347

Methylphenidate hydrochloride extended-release (LA) 30 mg TEVA 5347

Methylphenidate Hydrochloride Extended-Release (LA)

Imprint
TEVA 5347
Strength
30 mg
Color
White
Size
18.00 mm
Shape
Capsule/Oblong
Availability
Prescription only
Drug Class
CNS stimulants
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
2 - High potential for abuse
Labeler / Supplier
Teva Pharmaceuticals USA Inc.
National Drug Code (NDC)
00093-5347
Inactive Ingredients
ammonio methacrylate copolymer type B, ferrosoferric oxide, D&C Yellow No. 10, FD&C Blue No. 1, FD&C Blue No. 2, FD&C Red No. 40, hypromellose 2208 (3 mPa.s), methacrylic acid - methyl methacrylate copolymer (1:1), polyethylene glycol 6000, propylene glycol, shellac, corn starch, sucrose, magnesium silicate, titanium dioxide, triethyl citrate, D&C Red No. 33

Note: Inactive ingredients may vary.

Drug Uses Add to Drug List Print

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer